Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDJ93
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $98,274.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 through November 2026. The delivery will be fulfilled from the contractor's Park Ridge facility and represents a single line item pharmaceutical supply to support Department of Defense healthcare operations.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of delivery orders with the DLA, consistently competing effectively without set-aside designations despite its woman-owned small business status. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This particular delivery order for Keytruda, an oncology therapeutic agent, exemplifies the contractor's capability to supply specialized pharmaceutical products directly to DoD healthcare sites, contributing to the medical supply needs of military health facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FDJ93?
SPE2DB25FDJ93 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 6, 2025.
How much is contract SPE2DB25FDJ93 worth?
The government has obligated $98,275 on SPE2DB25FDJ93.
Is contract SPE2DB25FDJ93 an order under another contract?
Yes. SPE2DB25FDJ93 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ93 competed?
The extent of competition for SPE2DB25FDJ93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award